Cytokine, cell adhesion receptor, and tumor suppressor gene expression in vulvar squamous carcinoma: Correlation with prominent fibromyxoid stromal response

International Journal of Gynecological Pathology

Volumn 15, Issue 4, 1996, Pages 320-325

  Ambros, Robert A ^a   Kallakury, Bhaskar V S ^a   Malfetano, John H ^a   Mihm Jr , Martin C ^a  

^a ALBANY MEDICAL COLLEGE   (United States)

Author keywords

CD44; Cell adhesion receptors; Cytokines; Desmoplasia; p53 gene; Transforming growth factor ; Tumor suppressor genes; Vulvar carcinoma

Indexed keywords

CELL RECEPTOR; CYTOKINE; HERMES ANTIGEN; PROTEIN P53; TRANSFORMING GROWTH FACTOR BETA3;

ARTICLE; CANCER SURVIVAL; CLINICAL ARTICLE; FEMALE; GENE EXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; PROTEIN DETERMINATION; SQUAMOUS CELL CARCINOMA; TUMOR SUPPRESSOR GENE; VULVA CARCINOMA;

EID: 0029830631     PISSN: 02771691     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004347-199610000-00004     Document Type: Article

References (17)

1. Ambros R, Malfetano J, Mihm M. Clinicopathologic features of vulvar squamous carcinomas displaying prominent fibromyxoid stromal response. Int J Gynecol Pathol 1996;15: 137-45.
2. Cox DR. Regression models and life tables. J R Stat Soc Br 1972;32:187-98.
3. Knudson W, Biswas C, Toole BP. Interactions between human tumor cells and fibroblasts stimulate hyaluronate synthesis. Proc Natl Acad Sci USA 1984;81;6767-71.
4. Decker M, Chiu ES, Dollbaum C, et al. Hyaluronic acid stimulating activity in sera from the bovine fetus and from breast cancer patients. Cancer Res 1989;49:3499-505.
5. Border WA, Noble NA. Transforming growth factor B in tissue fibrosis. N Engl J Med 1994;331:1286-92.
6. Massague J. The transforming growth factor-B family. Annu Rev Cell Biol 1990;6:597-41.
7. Leof EB, Proper JA, Goustin AS, Shipley GD, DiCorleto PE, Moses HL. Induction of c-sis mRNA and activity similar to platelet-dervied growth factor by transforming growth factor B: a proposed model for indirect mitogenesis involving autocrine activity. Proc Natl Acad Sci USA 1986;83: 2453-7.
8. Salo T, Lyons JG, Rahemtulla F, Birkedal-Hansen H, Larjava H. Transforming growth factor B-1 up-regulates type IV collagenase expression in cultured human keratinocytes. J Biol Chem 1991;266:11436-41.
9. Reiss M, Stash EB. High frequency of resistance of human squamous carcinoma cells to the anti-proliferative action of transforming growth factor β. Cancer Commun 1990;2: 363-9.
10. Missero C, Ramon y Cajal R, Dotto GP. Escape from transforming growth factor β control and oncogene cooperation in skin tumor development. Proc Natl Acad Sci USA 1991;88: 9613-7.
11. Jalkanen STRF, Bargatze J, de los Toyos, Butcher EC. Lymphocyte recognition of high endothelium: antibodies to distinct epitopes of an 85-95 kD glycoprotein antigen differently inhibit lymphocyte binding to lymph node, mucosal, or synovial endothelial cells. J Cell Biol 1987;105:983-90.
12. Aruffo A, Stamenkovic I, Melnick M, Underhill CB, Seed B. CD44 is the principal cell surface receptor for hyaluronate. Cell 1990;61:1303-13.
13. Miyake K, Medina KL, Hayashi SI, Hamaoka S, Ono T Kincade P. Momoclonal antibodies to Pgp-1/CD44 block lymphopoiesis in long term bone marrow cultures. J Exp Med 1990;171:477-88.
14. Arch RK, Wirth K, Hofmann M, et al. Participation in normal immune responses of a metastasis-inducing splice variant of CD44. Science 1992;257:682-5.
15. Webb DSA, Shimizu Y, van Seventer GA, Shaw S, Gerard TL. LFA-3, CD44, and CD45: physiologic triggers of human monocyte TNF and IL-1 release. Science 1990;249:1295-7.
16. Thomas L, Etoh T, Stamenkovic I, Mihm MC, Byers HR. Migration of human melanoma cells on hyaluronate is related to CD44 expression. J Invest Dermatol 1993;100:115- 20.
17. Nesterova M, Cho-Chung YS. A single injection protein kinase A-directed antisense treatment to inhibit tumor growth. Nature Med 1995;1:528-33.